Statement/Regulatory AdmissionFormycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama® 18.11.2024 / 06:30 ...
GAT Sport® Reclaims GNC Shelves and Introduces Its Newest Nitraflex® ULTRA Pre-Workout in a Power Play That Strengthens Both ...
Actress and singer Victoria Summer, who also serves as an ambassador for Teen Cancer America, hosted the evening with a ...
Protective clothing has become a vital component of the life sciences industry, where rigorous safety standards are paramount for worker protection and maintaining sterile environments. As research, ...
Medtronic receives CE Mark for its next generation Endoflip TM 300 systemEndoflip TM is an advanced diagnostic tool that can ...
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...
The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...
Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024 / ...
MIDLAND, MI and SAINT JOHNS, MI / ACCESSWIRE / November 14, 2024 / Michigan Psychological Care is excited to announce the ...
Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc.
Eisai Europe Ltd. and Biogen Inc. announced today that a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
Waters Corporation (NYSE:WAT) announced the official opening of its new 45,000 square foot manufacturing facility at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback